Key result
Transcatheter aortic valve implantation in high-risk elderly patients with severe symptomatic aortic stenosis resulted in a 12-month all-cause mortality rate of 17.8%.
Population
101 consecutive high-risk elderly patients with severe symptomatic aortic stenosis, median age 81.0, 60.4%…
Design
Cohort
Follow-up
12 months
Authors
Loading...
May support consideration in selected high-risk elderly patients; leaves open need for randomized confirmation of benefit.
Observational (n=101)
No
TAVI is an effective treatment option for elderly, high-risk patients with severe symptomatic aortic stenosis, demonstrating an acceptable 12-month mortality rate of 17.8% and significant symptom alleviation.
Bagieński et al. (2016) conducted an observational in Severe symptomatic aortic stenosis (n=101). Transcatheter aortic valve implantation (TAVI) was evaluated on All-cause mortality at 12 months. Transcatheter aortic valve implantation in high-risk elderly patients with severe symptomatic aortic stenosis resulted in a 12-month all-cause mortality rate of 17.8%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: